
In the continuing effort to develop new medicines to treat schizophrenia , a team led by BBRF Scientific Council member...
Read More

A study covering the 20 years between 1997 and 2016 shows that substantial changes have occurred in the way doctors...
Read More

Cariprazine, a medicine approved by the FDA in 2015 for the treatment of manic episodes in bipolar I disorder ,...
Read More

Using machine-learning techniques to analyze functional imaging data, a team of Foundation-supported researchers reports that it was able to identify...
Read More
Genetic Variations Reveal Which Patients Will Have Cognitive Benefits From Antipsychotic Medications

Antipsychotic medications are a cornerstone of treatment for schizophrenia and related disorders. They prevent hallucinations and delusions for most people,...
Read More